Periodic Reporting for period 1 - GENEGUT (Oral delivery of encapsulated RNA nanotherapeutics for targeted treatment of ileal Crohn's disease)

The main aim of GENEGUT is to develop an orally administered medicine containing RNA to treat ileal Crohn’s disease. The success of the Covid 19 vaccine which contained mRNA, a nucleic acid, as the active ingredient has given confidence to the public in general that...